Biliary Stents Market Is Anticipated To Progress At A CAGR Of 5% By 2027

Biliary stent demand, now estimated at US$ 315.4 million, is anticipated to grow at a CAGR of 5% from 2022 to 2027. A stent is a tube made of plastic or metal that is inserted into a bodily cavity or duct to keep the channel open. The bile duct, a protracted, tube-like structure that transports bile fluid, is referred to as "biliary." Bile is essential for the digestion of meals. Biliary disorders are treated using biliary stents.

A paradigm shift in the management of biliary illnesses occurred in 1979 when biliary stents were first utilized to treat malignant biliary strictures. Biliary strictures, leaking bile ducts, and malignant biliary diseases are among the disorders for which biliary stents are used.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7698?PS

Global demand for biliary stents is expected to increase as more people around the world receive diagnoses of chronic liver disease and bile duct cancer.

The market is also anticipated to grow as a result of the fast rising number of minimally invasive surgeries and the usage of robotics, which allow doctors to accurately and adaptably complete a range of challenging treatments. Additionally, robotic-associated bile duct surgery has benefits over traditional surgery such quicker recovery times, reduced infection risks, and shorter hospital stays.

For instance,

The American Cancer Society (2021) estimates that 8,000 Americans would be diagnosed with bile duct cancer each year.
Since these tumours can frequently be difficult to identify and may be mistakenly categorized as another type of cancer, the real number of cases is anticipated to be greater. An existing tumour that is blocking the bile duct may become larger as a result of bile duct cancer. In such cases, biliary stent insertion can aid in optimal bile drainage.

𝐇𝐢𝐠𝐡 𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐍𝐞𝐞𝐝𝐢𝐧𝐠 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭

Due to advancements in gastrointestinal surgery over the past few decades, there are now more options for treating pancreatic and biliary diseases. Gastrointestinal remedies have fewer dangers than traditional open surgical procedures.

Surgery was the primary method of treatment for biliary obstruction prior to the development of stents. Pancreatic and biliary stents are used as the mainstay of pancreas divisum therapy, along with cutting-edge innovations such biodegradable biliary stents and bioabsorbable stents that have increased the options for the open surgical treatment of challenging lesions.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Global sales of biliary stents are projected to reach US$ 402.5 million by 2027.
• The hospitals segment is predicted to expand at a CAGR of 6% in the biliary stents market from 2022 to 2027.
• The market for biliary stents in China is anticipated to reach a valuation of US$ 83 million by 2027.
• Currently, biliary stent sales account for 2.3% share of the global stents market.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐁𝐢𝐥𝐢𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

By Type :

Metal Biliary Stents
Plastic Biliary Stents

By Application :

Bilio-pancreatic Leakages
Pancreatic Cancer
Benign Biliary Structures
Gallstones
Others

By End User :

Hospitals
Specialty Clinics
Ambulatory Surgical Centres
Others

By Region :

North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7698?PS

𝐖𝐢𝐧𝐧𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲

The biliary stents market is fragmented and characterized by oligopolistic rivalry between select groups of well-known manufacturers. The market has a patent pool, and therefore, established manufacturers are looking towards newer ways to generate income.

Several businesses, including Cook Medical Inc., CONMED Corporation, Boston Scientific Corporation, and many others, are vying for a higher market share in emerging markets due to the lucrative growth opportunities in these markets.

To increase their market shares, manufacturers of biliary stents are investing heavily and putting strong emphasis on the introduction of cutting-edge technologies.

For instance, in January 2019, AMG International GmbH's 'ARCHIMEDES' biodegradable biliary and pancreatic stents got European CE mark clearance.

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐁𝐢𝐥𝐢𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

Boston Scientific Corporation declared in October 2021 that its Advanix biliary plastic stents now have both the CE Mark and 510(k) clearance from the U.S. Food and Drug Administration. The clearance will expand the company's product line, increasing the company's revenue.

Olympus Corporation introduced its self-expanding metal stent, the HANAROSTENT, in July 2020. FDA 510(k) clearance has been granted for the Hanarostent biliary stent.
More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the biliary stents market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of type (metal biliary stents, plastic biliary stents), application (bilio-pancreatic leakages, pancreatic cancer, benign biliary structures, gallstones, others), and end user (hospitals, specialty clinics, ambulatory surgery centers, others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.